OBJECTIVES: To relate cardiovascular magnetic resonance-derived segmental wall motion and myocardial scarring and determine whether they are associated with postoperative mitral regurgitation following coronary artery bypass grafting and annuloplasty for severe functional ischemic mitral regurgitation. METHODS: From January 2001 to October 2006, 29 patients with grade >or=3+ chronic functional ischemic mitral regurgitation were studied using cardiovascular magnetic resonance. Wall motion abnormality was graded for 17 standard left ventricular myocardial segments (0 = none, 1+ = hypokinesis, 2+ = severe hypokinesis, 3+ = akinesis, 4+ = dyskinesis), as was degree of hyperenhancement (scarring). Postoperative mitral regurgitation was assessed longitudinally by 71 transthoracic echocardiograms. RESULTS: Wall motion abnormalities grade >or=2+ were present in most myocardial segments (median 13). Scar >25% was present in a median of 3 segments, and 44% of those were in the territory of the posterior papillary muscle. Nearly all segments (95%) with >25% scar had >or=2+ wall motion abnormality. Although 90% of patients had no mitral regurgitation at hospital discharge, by 6 months, 34% had mitral regurgitation grade >or=2+. There was little association between wall motion abnormality and recurrence of mitral regurgitation (P > .1). Seventy percent of patients with scar >25% in the posterior papillary muscle region exhibited postoperative mitral regurgitation of grade >or=2+ by 6 months, compared with 15% with score <or=25% (P = .07). CONCLUSIONS: In a pilot study of cardiovascular magnetic resonance imaging in severe functional ischemic mitral regurgitation, severity of posterior papillary muscle region scarring correlated with decreased segmental wall motion and mitral regurgitation early after coronary revascularization and annuloplasty. Routinely assessing scar burden may identify patients for whom annuloplasty alone is insufficient to eliminate mitral regurgitation.
OBJECTIVES: To relate cardiovascular magnetic resonance-derived segmental wall motion and myocardial scarring and determine whether they are associated with postoperative mitral regurgitation following coronary artery bypass grafting and annuloplasty for severe functional ischemic mitral regurgitation. METHODS: From January 2001 to October 2006, 29 patients with grade >or=3+ chronic functional ischemic mitral regurgitation were studied using cardiovascular magnetic resonance. Wall motion abnormality was graded for 17 standard left ventricular myocardial segments (0 = none, 1+ = hypokinesis, 2+ = severe hypokinesis, 3+ = akinesis, 4+ = dyskinesis), as was degree of hyperenhancement (scarring). Postoperative mitral regurgitation was assessed longitudinally by 71 transthoracic echocardiograms. RESULTS: Wall motion abnormalities grade >or=2+ were present in most myocardial segments (median 13). Scar >25% was present in a median of 3 segments, and 44% of those were in the territory of the posterior papillary muscle. Nearly all segments (95%) with >25% scar had >or=2+ wall motion abnormality. Although 90% of patients had no mitral regurgitation at hospital discharge, by 6 months, 34% had mitral regurgitation grade >or=2+. There was little association between wall motion abnormality and recurrence of mitral regurgitation (P > .1). Seventy percent of patients with scar >25% in the posterior papillary muscle region exhibited postoperative mitral regurgitation of grade >or=2+ by 6 months, compared with 15% with score <or=25% (P = .07). CONCLUSIONS: In a pilot study of cardiovascular magnetic resonance imaging in severe functional ischemic mitral regurgitation, severity of posterior papillary muscle region scarring correlated with decreased segmental wall motion and mitral regurgitation early after coronary revascularization and annuloplasty. Routinely assessing scar burden may identify patients for whom annuloplasty alone is insufficient to eliminate mitral regurgitation.
Authors: Peter K Smith; John D Puskas; Deborah D Ascheim; Pierre Voisine; Annetine C Gelijns; Alan J Moskowitz; Judy W Hung; Michael K Parides; Gorav Ailawadi; Louis P Perrault; Michael A Acker; Michael Argenziano; Vinod Thourani; James S Gammie; Marissa A Miller; Pierre Pagé; Jessica R Overbey; Emilia Bagiella; François Dagenais; Eugene H Blackstone; Irving L Kron; Daniel J Goldstein; Eric A Rose; Ellen G Moquete; Neal Jeffries; Timothy J Gardner; Patrick T O'Gara; John H Alexander; Robert E Michler Journal: N Engl J Med Date: 2014-11-18 Impact factor: 91.245
Authors: Romain Capoulade; Xin Zeng; Jessica R Overbey; Gorav Ailawadi; John H Alexander; Deborah Ascheim; Michael Bowdish; Annetine C Gelijns; Paul Grayburn; Irving L Kron; Robert A Levine; Michael J Mack; Serguei Melnitchouk; Robert E Michler; John C Mullen; Patrick O'Gara; Michael K Parides; Peter Smith; Pierre Voisine; Judy Hung Journal: Circulation Date: 2016-10-25 Impact factor: 29.690
Authors: Neil K Mehta; Jiwon Kim; Jonathan Y Siden; Sara Rodriguez-Diego; Javid Alakbarli; Antonino Di Franco; Jonathan W Weinsaft Journal: J Thorac Dis Date: 2017-04 Impact factor: 2.895